Our Blog

CRISPR: The Path to Clinical Trials

If you have read a newspaper lately, there is a good chance you have heard about CRISPR-Cas9, the versatile gene editing technology. Read more: xconomy.com

FDA permits clinical trials of Athenex oral cancer drug

The Buffalo biotech firm Athenex has received U.S. Food and Drug Administration permission to move forward with clinical trials for the oral form of Docetaxel, its highly potent cancer drug, the company announced this week. Read more: buffalonews.com